Business Development

Oncology is now a growth driver for Pierre Fabre’s pharmaceutical activities, via R&D and business partnerships with companies that have developed targeted therapies for cancer treatment (solid and hematologic tumors).

We focus on innovative products from the preclinical phase to late development phases: 

- Innovative products targeting sub-populations of patients with solid tumors such as skin cancers, including melanoma, gastrointestinal cancers, cancers affecting women, lung cancers, and so on.

- Targeted therapies aimed at oncogenes or the core signaling pathways involved in tumorigenesis and resistance. 

We are interested in various therapeutic classes, including small molecules, monoclonal antibodies, and antibody-drug conjugates.

Pierre Fabre is a leading player in the field of medical dermatology. 

As part of our growth strategy, we have identified three priority therapeutic areas: onco-dermatology (basal cell carcinoma, cell carcinoma, actinic keratosis, cutaneous lymphoma, adjunctive treatments for oncology therapies), rare skin diseases (genetic diseases, autoimmune and inflammatory diseases), and pediatric dermatology (atopic dermatitis, hemangioma, warts, molluscum contagiosum, etc.). 

Our franchise examines all drug candidates that have achieved clinical proof of concept.

We actively pursue partnerships to develop innovative treatments in the marketing or clinical development phase with proven efficacy in humans.

We are interested in various therapeutic classes including small molecules, monoclonal antibodies, and innovative therapy medicinal products.

Our global presence allows us to seek out partnerships in Europe, the USA, and Asia.

Our priorities include acquiring rights and working with partners to develop innovative ingredients with proven clinical efficacy for our formulas.

We also channel our efforts into formulation technologies, innovative packaging options, and electronic devices for dermo-cosmetic use.

Pierre Fabre has a long-standing portfolio focused on urology, gynecology and rheumatology. 

Urology is a priority when it comes to acquisitions and licensing agreements, essentially within Europe.

We offer you the chance to maximize your products’ potential through agreements tailored to your requirements, to provide patients with the therapeutic solutions they need.

Pierre Fabre also has recognized expertise in everyday health care products, through well-known brands such as Naturactive and Pierre Fabre Oral Care, for which we are on the lookout for natural health and oral health products.